MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Spinocerebellar ataxia type 2 (SCA2) and Seizures: Is There a Correlation?

    P. Bhatia, S. Kaur (Phoenix, USA)

    Objective: We describe 3 patients of SCA2 with seizures, a rare phenomenology. Background: Spinocerebellar ataxia (SCA) is a heterogenous group of autosomal dominant neurodegenerative ataxic…
  • 2024 International Congress

    Progressive Myoclonic Ataxia: Neuroinflammation and Autoantibodies Against Inhibitory Synapses and Herpes Viruses

    D. Labunskiy, S. Kiryukhina, N. Kurgaev, V. Podsevatkin, V. Kolmykov (Saransk, Russian Federation)

    Objective: Our goal was to study the autoimmune mechanisms of neuroinflammation in progressive myoclonic ataxia. Background: There are 2 different Ramsay Hunt syndromes named after…
  • 2024 International Congress

    4-Aminopyridine improves downbeat nystagmus in SCA27b: A case report

    S. Coulette, M. Philibert, JM. Trocello, B. Gaymard, C. Desjardins (Paris, France)

    Objective: To assess objective clinical improvement in video-oculography in a patient with SCA27b on 4-aminopyridine (4-AP) treatment. Background: Spinocerebellar ataxia 27b (SCA27b; MIM 620174) is…
  • 2024 International Congress

    Increased Risk of Suicidal Ideation in Patients with Spinocerebellar Ataxias

    C. Lin, L. Peppel, R. Lai, C. Rummey, P. Opal, J. Schmahmann, C. Gomez, H. Paulson, T. Zesiewicz, S. Perlman, G. Wilmot, S. Ying, C. Onyike, K. Bushara, M. Geschwind, K. Figueroa, S. Pulst, S. Subramony, A. Duquette, T. Ashizawa, A. Hamedani, M. Davis, S. Srinivasan, M. Burns, L. Moore, V. Shakkottai, L. Rosenthal, S. Kuo (Houston, USA)

    Objective: We aimed to investigate if individuals with spinocerebellar ataxias (SCAs) experience increased suicidal ideation and to identify associated factors. Background: Suicidality has been extensively…
  • 2024 International Congress

    Spinocerebellar ataxia type 2 specific microRNAs may have an effect on neurodegeneration.

    R. Singh, V. Swarup, I. Ahmad, V. Anand, I. Singh, M. Faruq, A. Srivastava (NEW DELHI, India)

    Objective: 1.Identification of microRNA in whole blood PBMCs of SCA2 patients .2.Target prediction and pathway analysis of  spinocerebellar ataxia type 2 identified miRNAs.  3.Validation of…
  • 2024 International Congress

    Baseline Data of the Mobilise-D Parkinson Cohort

    W. Maetzler, JM. Hausdorff, H. Gaßner, C. Hansen, A. Mirelman, L. Alcock, P. Brown, C. Becker, J. Garcia-Aymerich, L. Cordova-Rivera, P. Ginis, H. Hunter, I. Neatrour, J. Winkler, J. Kudelka, H. Hildesheim, M. Gordon, P. Goerrissen, B. Caulfield, M. Long, C. Schlenstedt, A. Nieuwboer, L. Rochester, AJ. Yarnall (Kiel, Germany)

    Objective: To report baseline data of the Parkinson’s disease (PD) cohort in the Mobilise-D project. Background: Mobility is one of the most affected domains in…
  • 2024 International Congress

    Acceptability and user experience of the electronic versions of the MDS-UPDRS and MDS-NMS scales

    M. Monje, R. Fuller, T. Turner, L. Chahine, K. Dujardin, C. Fitzer-Attas, S. Groppa, S. Perez-Lloret, J. Youn, S. Ali, P. Martinez-Martin, G. Stebbins, T. Mestre, A. Sánchez-Ferro (Chicago, USA)

    Objective: This study aims to evaluate the user experience of the newly developed electronic versions of the MDS Unified Parkinson's Disease Rating Scale (e-MDS-UPDRS) and…
  • 2024 International Congress

    Ethnic and Gender Disparities in Access to Deep Brain Stimulation: A Qualitative Exploration

    S. Corrick, J. Miyasaki, K. Yen, B. Salami, P. Torabi, G. Dimapilis, F. Ba (Edmonton, Canada)

    Objective: The objective of this qualitative inquiry is to explore the experiences of people with movement disorders in terms of ethnic and gender-related barriers to…
  • 2024 International Congress

    Dopamine Transporter Imaging as Monitoring Biomarker in Parkinson’s Disease

    V. Dzialas, G. Bischof, K. Möllenhoff, A. Drzezga, T. van Eimeren (Cologne, Germany)

    Objective: To investigate the longitudinal relationship between changes in dopamine transporter single-photon emission computed tomography (DaT SPECT) and changes in motor symptom severity in Parkinson’s…
  • 2024 International Congress

    Blautia argi ameliorates the motor impairment of 6-Hydroxydopamine hydrochloride-induced Parkinson’s disease rat model

    G. Tian, R. Zhou, J. Lu, W. Shi, R. Li, X. Guo (Xi'an, China)

    Objective: To evaluate the potential protective effects of Blautia argi on a 6-Hydroxydopamine (6-OHDA)-induced rat model of Parkinson's disease (PD). Background: PD is a common…
  • « Previous Page
  • 1
  • …
  • 456
  • 457
  • 458
  • 459
  • 460
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley